Protease-activated receptor 1 as a potential therapeutic target for COVID-19 (2021)
Source: Experimental Biology and Medicine. Unidade: FO
Subjects: COVID-19, CORONAVIRUS, TRANSTORNOS DA COAGULAÇÃO SANGUÍNEA
ABNT
ROVAI, Emanuel Silva e ALVES, Tomaz e CALDEIRA, Marinella Holzhausen. Protease-activated receptor 1 as a potential therapeutic target for COVID-19. Experimental Biology and Medicine, v. 246, n. 6, p. 688-94, 2021Tradução . . Disponível em: https://doi.org/10.1177/1535370220978372. Acesso em: 27 abr. 2024.APA
Rovai, E. S., Alves, T., & Caldeira, M. H. (2021). Protease-activated receptor 1 as a potential therapeutic target for COVID-19. Experimental Biology and Medicine, 246( 6), 688-94. doi:10.1177/1535370220978372NLM
Rovai ES, Alves T, Caldeira MH. Protease-activated receptor 1 as a potential therapeutic target for COVID-19 [Internet]. Experimental Biology and Medicine. 2021 ; 246( 6): 688-94.[citado 2024 abr. 27 ] Available from: https://doi.org/10.1177/1535370220978372Vancouver
Rovai ES, Alves T, Caldeira MH. Protease-activated receptor 1 as a potential therapeutic target for COVID-19 [Internet]. Experimental Biology and Medicine. 2021 ; 246( 6): 688-94.[citado 2024 abr. 27 ] Available from: https://doi.org/10.1177/1535370220978372